Anavex Life Sciences
AVXL
168 hedge funds and large institutions have $316M invested in Anavex Life Sciences in 2024 Q4 according to their latest regulatory filings, with 47 funds opening new positions, 50 increasing their positions, 39 reducing their positions, and 22 closing their positions.
114% more first-time investments, than exits
New positions opened: 47 | Existing positions closed: 22
106% more capital invested
Capital invested by funds: $153M → $316M (+$163M)
63% more call options, than puts
Call options by funds: $15.9M | Put options by funds: $9.78M
28% more repeat investments, than reductions
Existing positions increased: 50 | Existing positions reduced: 39
16% more funds holding
Funds holding: 145 → 168 (+23)
3.02% more ownership
Funds ownership: 31.82% → 34.84% (+3%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$6.89M |
| 2 |
Invesco
Atlanta,
Georgia
|
+$4.54M |
| 3 |
PC
Pier Capital
Stamford,
Connecticut
|
+$3.4M |
| 4 |
EP
Essential Planning
Portsmouth,
New Hampshire
|
+$3.18M |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$2.22M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
State Street
Boston,
Massachusetts
|
-$5.03M |
| 2 |
BlackRock
New York
|
-$1.45M |
| 3 |
Millennium Management
New York
|
-$1.02M |
| 4 |
Goldman Sachs
New York
|
-$950K |
| 5 |
ECM
ExodusPoint Capital Management
New York
|
-$723K |
AVXL Hedge Fund Activity: Q4 2024 in Review
168 of the 7,607 institutional investors tracked by Wall St. Rank reported a position in Anavex Life Sciences (AVXL) for Q4 2024, worth a combined $316M — up 106% from $153M a quarter earlier.
Buyers outnumbered sellers: 47 funds opened new AVXL positions and 22 closed out — a net gain of 25 holders — while 50 added to existing stakes and 39 trimmed.
The largest buyer was Susquehanna International Group, adding an estimated $6.89M. The largest seller was State Street, cutting an estimated $5.03M.
- 168 institutional investors held Anavex Life Sciences (AVXL) as of Q4 2024, up from 145 in Q3 2024.
- Funds reported $316M of Anavex Life Sciences stock for Q4 2024, up 106% quarter-over-quarter.
- 47 funds opened new Anavex Life Sciences positions in Q4 2024 and 22 closed out, a net change of +25 holders.
- The largest Anavex Life Sciences buyer in Q4 2024 was Susquehanna International Group, an estimated $6.89M added.
- The largest Anavex Life Sciences seller in Q4 2024 was State Street, an estimated $5.03M sold.
Based on aggregated 13F filings for Q4 2024.